Employees' support strategies for mental wellbeing during and beyond the COVID-19 pandemic: Recommendations for employers in the UK workforce.

Throughout the COVID-19 pandemic, and beyond for many businesses, employees have had to adapt to new ways of working due to disruptions in traditional practices. It is therefore crucial to understand the new challenges that employees are facing when it comes to taking care of their mental wellbeing at work. To that end, we distributed a survey to full-time UK employees (N = 451) to explore how supported they felt throughout the pandemic, and to identify whether there are any additional types of support they would like to receive.

Multicomponent odd-parity superconductivity in UAu at high pressure.

We report that high-quality single crystals of the hexagonal heavy fermion material uranium diauride (UAu) become superconducting at pressures above 3.2 GPa, the pressure at which an unusual antiferromagnetic state is suppressed. The antiferromagnetic state hosts a marginal fermi liquid and the pressure evolution of the resistivity within this state is found to be very different from that approaching a standard quantum phase transition.

New sustainable ternary copper phosphide thermoelectrics.

The thermoelectric performance of ACuP (A = Mg and Ca) with abundant elements and low gravimetric density is reported. Both systems are p-type doped by intrinsic Cu vacancy defects, have large power factors and promising figures of merit, reaching = 0.5 at 800 K.

Non-Fermi liquid behavior below the Néel temperature in the frustrated heavy fermion magnet UAu.

The term Fermi liquid is almost synonymous with the metallic state. The association is known to break down at quantum critical points (QCPs), but these require precise values of tuning parameters, such as pressure and applied magnetic field, to exactly suppress a continuous phase transition temperature to the absolute zero. Three-dimensional non-Fermi liquid states, apart from superconductivity, that are unshackled from a QCP are much rarer and are not currently well understood.

Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2.

Building on our previously-reported novel tricyclic topoisomerase inhibitors (NTTIs), we disclose the discovery of REDX07965, which has an MIC of 0.5 μg mL against , favourable pharmacokinetic properties, selectivity human topoisomerase II and an acceptable toxicity profile. The results herein validate a rational design approach to address the urgent unmet medical need for novel antibiotics.